Mallinckrodt Must Face Antitrust Claims Over Seizure Drug

By Mike Curley · August 14, 2020, 6:18 PM EDT

Mallinckrodt Ard LLC must face claims by Humana Inc. that it ran a scheme to keep a competitor to its infant spasm drug off the market after a California federal judge...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Humana, Inc. v. Mallinckrodt ARD LLC et al

Case Number

Court

California Central

Nature of Suit

Anti-Trust

Date Filed

August 08, 2019

Recent Articles By Mike

July 16, 2024
3rd Circ. Backs Tossing Over 1K Suits In Merck Vaccine MDL
June 28, 2024
Philips Gets OK For $25M Med Monitoring Deal In CPAP MDL
June 27, 2024
Whole Foods, Hain Want Full 5th Circ. Review Of Baby Food Suit
June 20, 2024
11th Circ. Upholds $2.5M Pelvic Mesh Verdict, Rules Suit Timely
June 18, 2024
COVID Test Maker Can't Shake All Of $30M Faulty Kit Suit
May 31, 2024
Weight Loss Drug Caused Stomach Paralysis, Suit Says
May 22, 2024
NC Panel Revives Retention Claim In Faulty Back Surgery Suit
May 21, 2024
Counties Not 'Persons' In Texas Opioid MDL Appeal
May 16, 2024
NY High Court Blocks Doctor's Hospital Shooting Injury Suit
May 09, 2024
Doc Can't Escape Second Prednisone Overprescribing Suit